Evidence map›Paper›PMID 38294939›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Bioorthogonal chemical labeling of endogenous neurotransmitter receptors in living mouse brains.

Hiroshi Nonaka, Seiji Sakamoto, Kazuki Shiraiwa, Mamoru Ishikawa, Tomonori Tamura, Kyohei Okuno, Takumi Kondo, Shigeki Kiyonaka, Etsuo A Susaki, Chika Shimizu and 5 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hiroshi NonakaDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.ORCID 0000-0003-4623-2926
Seiji SakamotoDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.ORCID 0000-0002-0605-0987
Kazuki ShiraiwaDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.
Mamoru IshikawaHamachi Innovative Molecular Technology for Neuroscience, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Kyoto 615-8530, Japan.
Tomonori TamuraDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.
Kyohei OkunoDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.
Takumi KondoDepartment of Biomolecular Engineering, Graduate School of Engineering, Nagoya University, Nagoya 464-8603, Japan.
Shigeki KiyonakaHamachi Innovative Molecular Technology for Neuroscience, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Kyoto 615-8530, Japan.ORCID 0000-0002-4100-6738
Etsuo A SusakiDepartment of Biochemistry and Systems Biomedicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Chika ShimizuLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka 565-5241, Japan.
Hiroki R UedaLaboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka 565-5241, Japan.ORCID 0000-0001-8342-9176
Wataru KakegawaHamachi Innovative Molecular Technology for Neuroscience, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Kyoto 615-8530, Japan.
Itaru AraiDepartment of Neurophysiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Michisuke YuzakiDepartment of Neurophysiology, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0002-5750-3544
Itaru HamachiDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) JP20gm6210027Japan Agency for Medical Research and Development (AMED) JP22am0401006Japan Agency for Medical Research and Development (AMED) JP22am0401011MEXT | Japan Society for the Promotion of Science (JSPS) 19H05764MEXT | Japan Society for the Promotion of Science (JSPS) 21J15773MEXT | Japan Society for the Promotion of Science (JSPS) 22H02824MEXT | Japan Society for the Promotion of Science (JSPS) JP18H05270MEXT | JST | Exploratory Research for Advanced Technology (ERATO) JPMJER1802MEXT | JST | Exploratory Research for Advanced Technology (ERATO) JPMJER2001Ministry of Education, Culture, Sports, Science and Technology (MEXT) JPMXS0120330644Mochida Memorial Foundation for Medical and Pharmaceutical Research ( ) No Grant Reference NumberNakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering (Nakatani Foundation) No Grant Reference NumberTakeda Science Foundation (TSF) No Grant Reference Number
6 · The paper itself

Abstract

Neurotransmitter receptors are essential components of synapses for communication between neurons in the brain. Because the spatiotemporal expression profiles and dynamics of neurotransmitter receptors involved in many functions are delicately governed in the brain, in vivo research tools with high spatiotemporal resolution for receptors in intact brains are highly desirable. Covalent labeling by chemical reaction (chemical labeling) of proteins without genetic manipulation is now a powerful method for analyzing receptors in vitro. However, selective target receptor labeling in the brain has not yet been achieved. This study shows that ligand-directed alkoxyacylimidazole (LDAI) chemistry can be used to selectively tether synthetic probes to target endogenous receptors in living mouse brains. The reactive LDAI reagents with negative charges were found to diffuse well over the whole brain and could selectively label target endogenous receptors, including AMPAR, NMDAR, mGlu1, and GABA

Indexed as

NeuronsProteinsAnimalsBrainIndicators and ReagentsLigandsMiceIndicators and ReagentsLigandsProteinsbioorthogonal reactionendogenous proteinligand-directed chemistryprotein labelingpulse–chase analysis

Identifiers

PMID38294939
PMCPMC10861872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.